Table 4.
Cox regression analysis of the factors for cumulative risk of re-exacerbation in patients with moderate to severe UC exacerbations.
| Variables | Univariate analysis | P | Multivariate analysis | P | ||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | Hazard ratio | 95% CI | |||
| Age, ≥ 60 years | 0.828 | 0.611–1.115 | 0.214 | 0.813 | 0.603–1.096 | 0.174 |
| First attack | 0.976 | 0.771–1.236 | 0.839 | 0.803 | 0.612–1.054 | 0.113 |
| Pancolitis UC | 1.227 | 1.015–1.484 | 0.035 | 1.217 | 1.065–1.391 | 0.004 |
| Severe exacerbation | 1.238 | 1.000–1.533 | 0.050 | 1.133 | 0.902–1.424 | 0.283 |
| History of COR-REF or DEP | 0.846 | 0.664–1.077 | 0.173 | 0.930 | 0.716–1.209 | 0.589 |
| 5-ASA | 1.046 | 0.859–1.274 | 0.652 | 1.161 | 0.911–1.480 | 0.226 |
| Corticosteroids | 1.436 | 1.164–1.772 | 0.001 | 1.473 | 1.183–1.833 | 0.001 |
| Apheresis | 0.992 | 0.803–1.226 | 0.944 | 0.977 | 0.785–1.216 | 0.837 |
| Calcineurin inhibitors | 1.115 | 0.886–1.404 | 0.353 | 1.206 | 0.939–1.549 | 0.142 |
| Immunomodulators | 1.051 | 0.754–1.467 | 0.768 | 1.066 | 0.760–1.480 | 0.712 |
| Biologics | 0.527 | 0.389–0.713 | < 0.001 | 0.501 | 0.367–0.683 | < 0.001 |